181 related articles for article (PubMed ID: 6354437)
21. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
22. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
[TBL] [Abstract][Full Text] [Related]
23. Ornithine decarboxylase--a predictor for tumor chemosensitivity.
Bachrach U; Shayovitz A; Marom Y; Ramu A; Ramu N
Cell Mol Biol (Noisy-le-grand); 1994 Nov; 40(7):957-64. PubMed ID: 7849562
[TBL] [Abstract][Full Text] [Related]
24. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
Satyamoorthy K; Deshpande SS; Chitnis MP
Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
[TBL] [Abstract][Full Text] [Related]
25. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
Lepri E; Menconi E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
[TBL] [Abstract][Full Text] [Related]
27. [Characteristics of anthracycline-resistant strains of P388 leukemia].
Goncharova SA; Demidova NS; Shiriaeva OA; Shevtsova VN; Konovalova NP
Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
[TBL] [Abstract][Full Text] [Related]
28. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
[TBL] [Abstract][Full Text] [Related]
29. Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia.
Inaba M; Sakurai Y
Cancer Lett; 1979 Dec; 8(2):111-5. PubMed ID: 555868
[TBL] [Abstract][Full Text] [Related]
30. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
Frankfurt OS
J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
[TBL] [Abstract][Full Text] [Related]
32. Class I MHC molecules and doxorubicin resistant P388 murine leukemic cells.
DiCicco LM; Lazarus H; Krishan A
Immunopharmacol Immunotoxicol; 1989; 11(4):583-92. PubMed ID: 2516859
[TBL] [Abstract][Full Text] [Related]
33. Exploring multidrug resistance using rhodamine 123.
Kessel D
Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
[TBL] [Abstract][Full Text] [Related]
34. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
35. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D; Schmidt H
Biochem Pharmacol; 1986 Feb; 35(4):673-8. PubMed ID: 3947398
[TBL] [Abstract][Full Text] [Related]
36. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
Chandrasekaran B; Dimling J; Capizzi RL
Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
[TBL] [Abstract][Full Text] [Related]
37. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
Nair S; Horton A; Leif RC; Krishan A
Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
[TBL] [Abstract][Full Text] [Related]
38. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
[TBL] [Abstract][Full Text] [Related]
39. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
Demidova NS; Goncharova SA; Shiriaeva OA; Konovalova NP
Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
Ramachandran C; You W; Krishan A
Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
